Business

Most COVID-19 vaccines are going to white people, even though the pandemic has ravaged communities of color

Dr. Michelle Chester preparing to administer a COVID-19 vaccine at Long Island Jewish Medical Center.
Scott Heins/Getty Images
Black people and other racial and ethnic minorities in the US have been hit hard by the coronavirus pandemic, but white people have so far gotten most of the COVID-19 shots, according to state data reviewed by Business Insider.
Business Insider reviewed vaccination data for six states that have high percentages of Black residents and that publish the information by race.
In each of the six states, vaccinations for Black people and other minorities lagged behind...
Read more ...

COVID-19 has killed more British civilians than the Nazis

19 days ago | By Business Insider

A nurse works on a patient in the ICU at St. George's Hospital in London on January 7, 2020.
Victoria Jones/PA Images via Getty Images
UK COVID-19 deaths are now higher than the number of British civilians killed in World War II.
Government figures state that 70,000 British civilians were killed during the war. Most of these deaths were due to bombing raids by Nazi Germany.
The coronavirus has now killed 78,508 people in the country.
This week, England and Scotland were plunged into new national lockdowns, and London's mayor declared a "major incidents" as hospitals were overwhelmed with...
Read more ...

BioNTech soars 7% after its vaccine appears to work against new variants of COVID-19

19 days ago | By Business Insider

Vincent Kalut / Photonews via Getty Images
BioNTech soared as much as 7% on Friday following reports that its COVID-19 vaccine is effective against a variant strain recently found in the UK. According to a lab study conducted by Pfizer, the vaccine was effective in neutralizing the virus with the N501Y mutation of the spike protein. New variants of the COVID-19 strain found in the UK and South Africa are thought to be more contagious than the original strain. Visit Business Insider's homepage for more stories. BioNTech jumped as much as 7% on Friday after a study was published showing that...
Read more ...

The EU has secured access to up to 300 million extra Pfizer doses, following criticism for its slow COVID-19 vaccine rollout

19 days ago | By Business Insider

The Commission is expected to approve other vaccines in the coming weeks and months.
Vincent Kalut / Photonews via Getty Images
The EU has secured access to 300 million more doses of Pfizer and BioNTech's COVID-19 vaccine, the European Commission president Ursula von der Leyen said Friday morning.
If it orders all 300 million doses, this would double its total supply of the shot.
The EU has faced criticism for its slow vaccine rollout but ordering more doses is unlikely to solve the problem, due to supply problems and slow distribution.
Visit Business Insider's homepage for more stories...
Read more ...

Moderna's COVID-19 vaccine becomes the third shot approved for use in the UK

19 days ago | By Business Insider

Boxes containing the Moderna COVID-19 vaccine are prepared to be shipped.
AP Photo/Paul Sancya, Pool
The UK has approved the COVID-19 vaccine developed by Moderna, which proved 94% effective in late-stage trials in November.
The UK government has ordered 17 million doses of Moderna's shot, but it's unlikely to roll out before March, according to a statement.
The UK's health and social care secretary Matt Hancock described the vaccine as "another weapon in our arsenal to tame this awful disease."
Visit Business Insider's homepage for more stories .
The UK approved Moderna's COVID-19 vaccine...
Read more ...

The UK has two new 'life-saving' COVID-19 treatments that cut the death risk by 24% in critically unwell people. Experts say it's not a miracle cure but is 'clearly useful'

19 days ago | By Business Insider

A patient on a ventilator at Houston's United Memorial Medical Center.
Carolyn Cole/Los Angeles Times via Getty Images
Two new "life-saving" treatments can now be used in UK hospitals, because they reduce the risk of death by 24% in people critically unwell with coronavirus - according to a preliminary study.
Tocilizumab and sarilumab, anti-inflammatory drugs usually used for arthritis, can reduce the length of time in hospital by 10 days, the UK government announced on Thursday.
The treatments have not been tested on people with coronavirus on normal hospital wards, or in the...
Read more ...